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INTRODUCTION: 
 
The patients who undergo cardiac surgery in our hospital can be mainly divided into two 
groups. The first group of patients are who have coronary artery disease and the second 
group of patients are those with valvular heart disease. The first group of patients 
undergo coronary artery bypass grafting and the second group undergo valve repair or 
replacement. These patients will undergo these surgeries under cardiopulmonary bypass. 
They are in different class on the New York  Heart Association’s physical status 
classification. Based on the severity of the disease and the symptoms, these patients are 
treated with different  group of medications. As the disease advances these patients 
develop cardiac failure. When systolic heart failure occur, the heart can  no more pump 
adequate amount of blood into the systemic circulation leading to symptoms of low 
cardic output or of the fluid overload to the heart . When diastolic dysfunction occur, the 
patients develop heart failure due to atrial hypertension. Congestive cardiac failure leads 
to the symptoms like easy fatiguability, dyspnea and congestion. The medical 
management of heart failure includes angiotensin converting enzyme inhibitors, diuretics, 
vasodilators and digitalis. Diuretics are used to relieve circulatory congestion. Symptoms  
improve as the pulmonary and peripheral edema are relieved. Diuretics reduce atrial and 
ventricular diastolic pressures thereby reducing the diastolic stress on the ventricular 
wall. This will help in preventing persistent cardiac distension and improve 
subendocardial perfusion. Chronic use of diuretics will lead to hypokalemia. So 
potassium supplementation is given in patients on chronic diuretics use. Potassium 
sparing diuretics helps in avoiding hypokalemia but they will not cause adequate 
natriuresis. Hypokalemia or hyperkalemia in the perioperative period cause cardiac 
conduction disturbances  and they are not desirable. There are various factors  in the 
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perioperative period which can alter potassium homeostasis like the prescence of diabetic 
mellitus, hypertension, chronic renal failure, ischemic and valvular heart  diseases, 
respiratory and metabolic acid-base disturbances, hypothermia, blood transfusion, dose 
and duration of the   use of cardioplegia. The potassium homeostasis is maintained by 
giving potassium correction in the form of intravenous potassium in hypokalemia and by 
giving calcium, sodium bicarbonate, glucose-insulin infusion, nebulization with beta 2 
agonists when hyperkalemia occurs. 
 
This is an observational study to study the role of preoperative use of diuretics in the  
incidence of altered serum  potassium levels in the perioperative period. We compared 
two group of patients with one group on long term preoperative diuretic and the other 
group not on diuretics. This study helped us to understand whether diuretics played a role 
in the perioperative potassium homeostasis. 
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AIMS AND OBJECTIVES: 
 
1. To study the differences in the perioperative serum potassium changes between  one 
group of patients on long term preoperative diuretics and the second group of patients 
who were not on preoperative diuretics who  underwent openheart surgery under 
cardiopulmonary bypass. 
 
2.To compare the interventions needed to keep potassium homeostasis between the two 
groups. 
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REVIEW OF LITERATURE: 
 
POTASSIUM: 
Potassium is the fairly abundant positive ion in the intracellular compartment. (1) The 
total body potassium content is about 135 gms. Out of this 98 percent is present 
intracellular compartment (2) and about  two percent in the extracellular compartment. 
Potassium plays an important role in (3)  cell membrane physiology, especially in 
maintaining resting membrane potentials and in generating action potentials in the central 
nervous system and heart. 
NORMAL POTASSIUM BALANCE: ( 4 ) 
Normal serum potassium is between 3.5MEq/L to 5.5 MEq/L. The normal homeostasis 
of potassium is balanced between dietry intake and excretion through kidneys and gut; 
and also  by its movements between intracellular and extracellular compartments. 
Increase in the extracellular potassium is sensed by the zona glomerulosa cells of the 
adrenal medulla which secretes aldosterone. Aldosterone acts on the cortical collecting 
tubules and increases potassium secretion into the tubular fluid increasing potassium 
excretion.  
 
EXTRACELLULAR POTASSIUM REGULATION: 
The cell membrane  Na
+ 
-K
+
 ATPase  activity is important in controlling the distribution 
of potassium between cells and the extracellular fluid. The excretion of potassium 
through the kidneys is determined by the serum potassium concentration. Generally 
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extracellular serum potassium concentration reflects the balance between potassium 
intake and excretion. 
INTRACOMPARTMENTAL SHIFTS OF POTASSIUM: 
Intracompartmental shifts of potassium occur following any changes in the following: 
1.Extracellular pH. 
2. circulating catecholamine activity. 
3. circulating insulin levels. 
4. plasma osmolality. 
5. hypothermia. 
Insulin enhances the activity of membrane-bound Na
+–K+ ATPase, increasing cellular 
uptake of potassium in the liver and in skeletal muscle. When the pH is on the acidotic 
side, extracellular hydrogen ions enter cells, displacing intracellular potassium ions to 
maintain electrical neutrality. In alkalosis, the reverse will happen and extracellular 
potassium ions move into cells decreasing serum potassium concentration. Sympathetic 
stimulation increases intracellular uptake of potassium by enhancing Na
+–K+ ATPase 
activity. This effect is mediated through activation of beta 2 adrenergic receptors. Serum 
potassium concentration decreases following the administration of beta2-adrenergic 
agonists as a result of uptake of potassium by muscle and the liver. Acute increases in  
plasma osmolality increase serum potassium concentration. In such instances, the 
movement of water out of cells, down its osmotic gradient  is accompanied by movement 
of K
+
 out of cells. Hypothermia has been reported to lower serum potassium 
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concentration as a result of cellular uptake. Rewarming reverses this shift and may result 
in transient hyperkalemia if potassium was given during the hypothermia. 
ROLE OF POTASSIUM IN GENERATING ACTION POTENTIAL: ( 5 ) 
The cell membrane of cardiac muscle is more permeable to K
+
 but is relatively 
impermeable to Na
+
. The membrane-bound enzyme Na
+–K+-ATPase concentrates K+ 
intracellularly by extruding Na
+
 out of the cells. The concentration of Na
+
 inside the cell  
is low but the concentration of K
+
 is kept high inside the cells when comparing to its 
extracellular concentration. The cell membrane is also relatively impermeable to calcium 
which helps in maintaining a high extracellular to cytoplasmic calcium gradient. When 
K
+
 move out of the cell along its concentration gradient it results in a net loss of positive 
charges from inside the cell. This will lead to an electrical potential difference across the 
cell membrane as the anions do not come out along with K
+
. This results in the inside of 
the cell more negative when comparing to the extracellular environment. Thus a resting 
membrane potential develops which is the balance between two opposing forces – one 
being the movement of potassium out of the cell along its concentration gradient and the 
other being the electrical attraction of the negatively charged intracellular space with its 
attraction for the K
+
 ions.
 
The resting membrane potential of a ventricular cell is –80 to –90 mV. A characteristic 
action potential develop when the the cell membrane potential reaches a threshold value 
and becoming less negative. 
 
The membrane potential of the myocardial cell raises to + 20 mV transiently as a 
 
result of the generated action potential causing a spike. This spike is followed by a 
plateau phase of 0.2 to 0.3 seconds duration. The action potential of the myocardial cell 
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is due to opening of fast sodium channels which cause the spike and a slower calcium 
channels which cause the plateau phase in contrast with the action potential of the 
skeletal muscle and nerves which is caused by the sudden opening of the fast sodium 
channel only. Accompanied by depolarization is a transient decrease in potassium 
permeability. The membrane potential is eventually restored to normal by the restoration 
of the normal potassium permeability.  
After depolarization, the myocardial cells are refractory to subsequent depolarizing 
stimuli until phase 4. The minimum interval between two depolarizing impulses that are 
propagated is called the effective refractory period. In myocardial cells which are fast 
conducting, the effective refractory period is closely correlated with the action potential 
duration. 
 
ION CHANNELS IN CARDIAC MUSCLE MEMBRANE: ( 6 ) 
The sodium channel is voltage gated. It has an outer (m)gate that will open at  -60 to  -
70mV and an inner (h) gate that will close at -30mV. The calcium channel is voltage 
gated. Transient or T- type calcium channels act during phase 0 of depolariration. The 
slow L-type or the long-lasting calcium channels allows calcium inflow during the 
plateau phase. Potassium channels play a role in repolarization. There are three major 
types of potassium channels. They are ITo  which results in a transient outward potassium 
current,   IKr  which is responsible for a short rectifying current and  IKs  which produces a 
slowly acting rectifying current that restores the resting membrane potential. 
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CARDIAC ION CHANNELS: ( 7 ) 
VOLTAGE-GATED CHANNELS 
                   Na
+ 
                   T Ca
2+ 
                   L Ca
2+ 
                   K
+ 
                                    Transient outward 
                                    Inward rectifying 
                                    Slow ( delayed ) rectifying 
LIGAND-GATED K
+  
CHANNELS 
                    Ca
+ 
activated 
                    Na
+  
activated 
                    ATP sensitive 
                    Acetylcholine activated 
                     Arachadonic acid activated 
 
 
 
 
 
EVENTS IN CARDIAC ACTION POTENTIAL: ( 8 ) 
PHASE NAME EVENT CELLULAR ION 
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MOVEMENT 
0 Upstroke Activation (opening) 
of fast Na
+   
channels 
Na
+
 in and 
decreased 
permeability to K
+
 
1              Early rapid 
repolarization 
Inactivation of Na
+ 
channel and 
transient increase in 
K
+  
permeability 
 
K
+
 out (ITo)  
 
2          Plateau Activation of slow 
Ca
2+ 
channels 
Ca
2+
 in  
3  
Final repolarization 
Inactivation of Ca
2+ 
channels and 
increased 
permeability to K
+ 
 
K
+
 out  
4 Resting potential Normal permeability 
restored( atrial and 
ventricular cells) 
K
+
 out Na
+
 in  
 Diastolic 
repolarization 
Intrinsic slow 
leakage of  Ca
2+ 
into 
cells that 
spontaneously 
depolarize 
 
Ca
2+
 in  
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 ACTION POTENTIAL WAVES AND GRAPHS: 
 
FIVE PHASES OF CARDIAC ACTION POTENTIAL:  ( 9 ) 
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PACE MAKER ACTION POTENTIAL: ( 9 ) 
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HYPOKALEMIA: 
Hypokalemia is defined as a serum potassium concentration less than 3.5 mEq/L which 
may occur because of an absolute deficiency or redistribution into the intracellular space. 
The deficiency may be due to increased potassium loss or an inadequate potassium 
intake.  When the urinary potassium is greater than 20 mEq/L it indicates potassium 
losses through kidneys.It will be less than 20 mEq/L when the potassium loss is through 
gastrointestinal tract or due to inadequate intake.( 10 ) 
 
CAUSES OF HYPOKALEMIA: ( 11 ) 
 
HYPOKALEMIA DUE TO INCREASED RENAL POTASSIUM LOSS: 
Loop diuretics 
Thiazide diuretics 
High- dose glucocorticoids 
Mineralocorticoids 
High- dose antibiotics like penicillin, nafcillin, ampicillin 
Drugs associated with magnesium depletion like aminoglycosides 
Hyperglycemia 
Surgical trauma 
Hyperaldosteronism 
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HYPOKALEMIA DUE TO EXCESSIVE GASTROINTESTINAL LOSS OF 
POTASSIUM: 
Vomiting and diarrhea 
Zollinger- Ellison syndrome 
Malabsorption 
Nasogastric suction 
Chemotherapy 
 
HYPOKALEMIA DUE TO TRANSCELLULAR POTASSIUM SHIFT: 
Insulin 
Tocolytic drugs like ritodrine 
Beta adrenergic agonists 
Respiratory or metabolic alkalosis 
Hypercalcemia 
Hypomagnesemia 
Familial periodic paralysis 
 
CLINICAL MANIFESTATIONS OF HYPOKALEMIA: ( 12 ) 
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Hypokalemia can lead to widespread organ dysfunction. Symptoms may not occur in 
most patients till plasma [K
+
] is 3 mEq/L. The cardiovascular system is affected most. 
Hypokalemia can be manifested as an abnormal electrocardiogram , arrhythmias, 
decreased cardiac contractility, and a  labile arterial blood pressure due to autonomic 
dysfunction. Chronic hypokalemia can also cause myocardial fibrosis. Electrocardiogram 
changes are primarily due to delayed ventricular  repolarization. It includes T-wave 
flattening and inversion, an increasingly prominent U wave, ST-segment depression, 
increased P-wave amplitude, and prolongation of the P-R interval. Increased  myocardial 
cell automaticity and delayed repolarization promote both atrial and 
ventriculararrhythmias.   
                              
T wave inversion and prominent U waves in hypokalaemia 
 
 
 
 Apparent long QT interval with hypokalaemia (actually T-U fusion) 
 
23 
 
 
 
CLINICAL MANIFESTATIONS OF HYPOKALEMIA. 
             
CARDIOVASCULAR:  ECG changes 
                    Myocardial dysfunction 
NEUROMUSCULAR:   Skeletal muscle weakness 
                    Tetany 
                    Rhabdomyolysis 
                    Ileus                                                 
 RENAL:                       Polyura 
                                      Increased ammonia production 
                                      Increased bicarbonate reabsorbtion 
HORMONAL:              Decreased insulin secretion  
                                     Decreased bicarbonate secretion. 
METABOLIC:              Negative nitrogen balance 
                                     Encephalopathy in patients with liver disease 
MANAGEMENT OF HYPOKALEMIA: ( 13 ) 
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The treatment of hypokalemia depends on the presence of any associated organ 
dysfunction. No studies show increased morbidity or mortality for patients undergoing 
anesthesia with a potassium level of at least 2.6 mEq/L.  
 
The treatment of hypokalemia consists of potassium  repletion, correction of alkalemia, 
and removal of offending drugs. If the hypokalemia is due to depletion of total body 
potassium, oral supplementation of potassium is generally adequate. Intravenous 
potassium is indicated when there are cardiac symptoms or muscle weakness. The serum 
potassium levels and electrocardiography should be monitored continuosly to avoid 
inadvertent hyperkalemia. The typical replacement rate is 10 to 20 MEq/hr in an average 
sized adult through a central venous catheter because the rate of administration of 
potassium must be adjusted for the rate of distribution through the extracellular space 
before entry into the intracellular space. A peripheral line cannot be used for a correction 
exceeding more than 8 MEq/hr. Intravenous replacement should generally not exceed 
240 mEq/d. In hyperaldosteronemia such as primary aldosteronism and Cushing 
syndrome, hypokalemia usually responds to  reduced sodium  intake and increased 
potassium intake. The effects of hypokalemia is aggravated by the presence of 
hypomagnesemia, hence it should be treated promptly. In patients with diabetes mellitus 
or renal disease, potassium supplements or potassium sparing diuretics should be given 
carefully as an acute hyperkalemia may develop. In diabetic ketoacidosis the patients are 
hypokalemic as well as acidemic. Hence correction of acidosis should be preceeded by 
potassium supplementation to avoid acute decrease in serum potassium concentration as 
pH increases. 
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HYPERKALEMIA:  
Hyperkalemia is defined as a serum potassium concentration of  more than 5.5 MEq/L. 
Hyperkalemia can be caused by increased intake, diminished excretion and due to 
intercompartmental shifts. It can occur in various disease states. 
CAUSES OF HYPERKALEMIA: ( 14 ) 
INCREASED TOTAL BODY POTASSIUM CONTENT: 
Acute oliguric renal failure 
Chronic renal disease 
Hypoaldosteronism 
Drugs that impair potassium excretion like triamterene, spironolactone, NSAIDS. 
Drugs that inhibit the rennin- angiotensin- aldosterone system 
ALTERED TRANSCELLULAR POTASSIUM SHIFT: 
Succinylcholine 
Respiratiry and metabolic acidosis 
Iatrogenic bolus 
Lysis of cells due to chemotherapy 
PSEUDOHYPERKALEMIA: 
Hemolysis of blood specimen 
Thrombocytosis/leucocytosis 
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 CLINICAL MANIFESTATIONS OF HYPERKALEMIA: 
Hyperkalemia can be due to acute or chronic processes in the body. Acute hyperkalemia 
is poorly  tolerated than the chronic one. The common cause for chronic hyperkalemia 
associated with anaesthesia is renal failure. The most important effects of hyperkalemia 
are primarily on the skeletal and cardiac muscles. Alterations in cardiac conduction 
increase and enhance  repolarization.  
Mild elevations in potassium levels (6 to 7 mEq/L) may manifest with peaked T waves. 
when the levels approach 10 to 12 mEq/L, a prolonged P–R interval, widening of the 
QRS complex, ventricular fibrillation, or asystole can occur.( 15 )Contractility appears to 
be relatively well preserved. Hypocalcemia, hyponatremia, and acidosis accentuate the 
cardiac effects of hyperkalemia. 
 
EARLY ECG CHANGES SHOWING PEAKED T WAVES: 
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  EARLY ECG CHANGES SHOWING PEAKED T WAVES: 
 
 
 
 POTASSIUM OF 9.0 MMOL/L: 
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TREATMENT OF HYPERKALEMIA: ( 16 ) 
Treatment of hyperkalaemia includes stabilizing the myocardium to prevent arrhythmias, 
shifting potassium back into the intracellular space and removing excess potassium from 
the body. 
1.CORRECTION OF SERIOUS CONDUCTION ABNORMALITIES: 
Calcium gluconate or calcium chloride is used.Calcium is a very useful agent. It does not 
lower the serum potassium level, but instead is used to stabilise the myocardium, as a 
temporising measure.Calcium is indicated if there is widening of QRS, sine wave pattern 
(when S and T waves merge together), or in hyperkalaemic cardiac arrest. The ‘cardiac 
membrane stabilising effects’ take about 15-30min. 
2. DRIVING OF POTASSIUM INTO THE CELL: 
Intravenous fast acting insulin (actrapid) 10-20 units and glucose/dextrose 50g 25-50ml 
is usually used to drive potassium in to the cell.Insulin drives potassium into cells and 
administering glucose prevents hypoglycaemia. It will begin to work in 20-30mins. It 
reduces potassium by 1mmol/L and ECG changes within the first hour. 
Sodium Bicarbonate is used in the dosage of 50- 200mmol of 8.4% Sodium bicarbonate. 
Bicarbonate is only effective at driving Potassium intracellullarly if the patient  is 
acidotic. It will begin working in 30-60 minutes and continues to work for several hours.  
Salbutamol is usually given as a nebulisation. The dose is 10-20mg via nebulizer.Beta 2 
agonist therapy lower potassium through either IV or nebulizer route. Salbutamol can 
lower potassium level 1mmol/L in about 30 minutes, and maintain it for up to 2 hours. It 
is very effective in renal patients who are prone for fluid overload. 
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3. ELIMINATION OF POTASSIUM FROM THE BODY: 
Calcium Resonium is given in the dosage range of 15-45g orally or rectally usually 
mixed with lactulose or sorbitol. Calcium polystyrene sulfonate is a large insoluble 
molecule which will bind to potassium in the large intestine and it is excreted in faeces. 
The onset of action will be in two to three hours.  
Furosemide, the loop diuretic is used as a intravenous bolus of 20-80mg depending on 
hydration status. It excretes potassium in the urine. 0.9% Saline is used to help renally 
excrete potassium, by increasing renal perfusion and urinary output. It is used with 
caution in patients with cardiac and kidney failure.Dialysis  is considered to be the gold 
standard method for removing potassium from the body. It can provide immediate and 
reliable removal. About 1mmol/L of potassium is removed in the first hour and another 
1mmol/L over the next 2 hours.  
 
DIURETCS: ( 17 ) 
Diuretics are defined as the drugs used to increase the rate of flow of urine. The 
commonly used diuretics in clinical practice also increase the rate of Na
+
 excretion which 
is accompanied by excretion of an anion usually Cl
-
. NaCl in the body is the major 
determinant of extracellular fluid volume. Diuretics are directed toward reducing 
extracellular fluid volume by decreasing total-body NaCl content.  
A sustained imbalance between dietary Na
+
 intake and Na
+
 loss is incompatible with life. 
A sustained positive Na
+
 balance would result in volume overload with pulmonary 
edema, and a sustained negative Na
+
 balance would result in volume depletion and 
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cardiovascular collapse. Although continued administration of a diuretic causes a 
sustained net deficit in total-body Na
+
, the time course of natriuresis is finite because 
renal compensatory mechanisms bring Na
+
 excretion in line with Na
+
 intake, a 
phenomenon known as diuretic braking . These compensatory, or braking, mechanisms 
include activation of the sympathetic nervous system, activation of the renin-angiotensin 
-aldosterone axis, decreased arterial blood pressure (which reduces pressure natriuresis), 
hypertrophy of renal epithelial cells, increased expression of renal epithelial transporters, 
and perhaps alterations in natriuretic hormones such as atrial natriuretic peptide. 
Diuretics not only alter the excretion of Na
+
 but also may modify renal handling of other 
cations  e.g., K
+
, H
+
, Ca
2+
, and Mg
2+
, anions e.g., Cl
-
, HCO3 
-
, and H2PO4 
-
, and uric acid. 
In addition, diuretics  may alter renal hemodynamics indirectly. 
 
MAJOR CLASSES OF DIURETICS : 
 1  Loop diuretics 
2  Thiazide and thiazide-like diuretics 
3  Potassium sparing diuretics 
4  Aldosterone antagonists 
5  Non competitive potassium sparing diuretics 
6  Osmotic diuretics 
7  Carbonic anhydrase inhibitors. 
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Of these various classes of diuretics the commonly used ones in cardiac surgical patients 
are the loop diuretics, the thiazides and the potassium sparing diuretics. ( 18 ) 
 
SITES OF ACTION OF THE DIURETICS IN THE NEPHRON: ( 19 ) 
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 LOOP DIURETICS: 
 
Furosemide, bumetanide, ethacrynic acid, torsemide are the loop diuretics available. Of 
these furosemide commonly known as lasix is used in patients in valvular heart disease 
and in ischemic heart disease to avoid fluid overload in a failing heart.  
 
Loop diuretics inhibit Na
+
 and Cl
–
  reabsorption in the thick ascending limb. Sodium 
reabsorption in the ascending limb requires that all four sites on the Na
+–K+–2Cl– 
luminal carrier protein be occupied. Furosemide competes with Cl
–
 for its binding site on 
the carrier protein. It can lead to excretion of upto 15–20% of the filtered sodium load. It 
impairs both urinary concentrating and urinary diluting capacities. The large amounts of 
Na
+
 and Cl
–
 presented to the distal nephron overwhelm its limited reabsorptive 
capability. The resulting urine remains hypotonic.  
 
Loop diuretics are used in the treatment of edematous states like ( 20 ) heart failure, 
cirrhosis, the nephritic syndrome and renal insufficiency. It can reverse the cardiac and 
pulmonary manifestations rapidly when given in intravenous route. Loop diuretics are 
also used in the treatment of hypertension as an adjunct with other drugs and also in the 
treatment of hyponatremia when rapid correction is needed. (21 ) 
 
The intravenous doses are furosemide, 20–100 mg; bumetanide, 0.5–1 mg; ethacrynic 
acid, 50–100 mg; and torsemide 10–100 mg 
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MECHANISM AND SITE OF ACTION OF LOOP DIURETICS: 
 
  
 
 
 
SIDE EFFECTS OF LOOP DIURETICS: 
 
Increased delivery of Na
+
 to the distal and collecting tubules increases K
+
 and H
+
 
secretion at those sites and can result in hypokalemia and metabolic alkalosis. Marked 
Na
+
 losses will also lead to hypovolemia and prerenal azotemia. Hypercalciuria can result 
in stone formation and occasionally hypocalcemia. Hypomagnesemia may be seen in 
patients receiving long-term therapy. 
 
 Hyperuricemia is thought to result from increased urate reabsorption and competitive 
inhibition of urate secretion in the proximal tubule. Reversible hearing loss has been 
reported with both furosemide and ethacrynic acid but may be more common with 
ethacrynic acid. 
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THIAZIDE- TYPE DIURETICS:  
 
This group includes thiazides, chlorthalidone, quinethazone, metolazone and indapamide. 
Of these the thiazides are the commonly used one. They act on the distal tubule and the 
connecting segment and inhibits sodium reabsorption impairing diluting but not the 
concentrating abiity of urine. The thiazide diuretics compete for the Cl
–
 site on the 
luminal Na
+–Cl– carrier protein. ( 22 ) Thiazide diuretics increase Na+ excretion to only 
3–5% of the filtered load because of enhanced compensatory Na+ reabsorption in the 
collecting tubules. They also have some carbonic anhydrase inhibiting activity in the 
proximal tubule. This is normally masked by sodium reabsorption in the loop of Henle 
but is probably responsible for the often marked ("high ceiling") diuresis seen when 
thiazides are combined with loop diuretics. Thiazide diuretics augment Ca
2+
 reabsorption 
in the distal tubule. 
MECHANISM AND SITE OF ACTION OF THIAZIDE-LIKE DIURETICS 
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USES OF THIAZIDES: 
Thiazides are often the first-line agents in the treatment of hypertension. ( 23 ) Thiazides 
are  used as oral agents for mild to moderate sodium overload. Thiazide diuretics are 
often used to decrease calcium excretion in patients with hypercalciuria who form renal 
stones. They are also used in the treatment of  nephrogenic diabetic insipidus. 
 
SIDE EFFECTS OF THIAZIDES:  
 
Although thiazide-type diuretics deliver less sodium to the collecting tubules than loop 
diuretics, the increase in sodium excretion is enough to enhance K
+
 secretion and 
frequently results in hypokalemia. Enhanced H
+
 secretion can also occur, enough to 
result in metabolic alkalosis. Impairment of renal diluting capacity may produce 
hyponatremia in some patients. Hyperuricemia, hyperglycemia, hypercalcemia, and  
hyperlipidemia may also be seen. 
 
POTASSIUM-SPARING DIURETICS: (24 ) 
There are two types of potassium sparing diuretics namely 
 
1. Aldosterone antagonists. 
2. Non competitive potassium sparing diuretics. 
 Potassium sparing diuretics prevent  potassium excretion but can cause             
hyperkalemia. Spironolactone is a direct aldosterone receptor antagonist in collecting 
tubules. It acts to inhibit aldosterone-mediated Na
+
 reabsorption and K
+
 secretion. As a 
result, spironolactone is effective only in patients with hyperaldosteronism. 
Spironolactone is only given orally. 
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Triamterene and amiloride  which are sodium channel inhibitors do not dependent on 
aldosterone activity. They decrease  the number of open sodium channels in the 
collecting tubules’ luminal membrane leading to inhibition of sodium reabsorption and 
potassium secretion. Amiloride also inhibits Na
+
-K
+
- ATPase activity in the collecting 
tubules. They are also given only orally.  
 
SIDE EFFECTS OF POTASSIUM SPARING DIURETICS: 
Spironolactone can result in hyperkalemia in patients with high potassium intake or renal 
insufficiency and in those receiving beta-blockers or ACE inhibitors. Metabolic acidosis 
may also be seen. Other side effects include diarrhea, lethargy, ataxia, gynecomastia, and 
sexual dysfunction. 
Amiloride and triamterene retain potassium causing significant hyperkalemia and 
metabolic acidosis. They may lead to nausea, diarrhoea and vomiting. Amiloride cause 
fewer side effects than triamterene. 
 
 
CARDIOPULMONARY BYPASS: ( 25 ) 
 
Cardiopulmonary bypass or CPB, a form of extracorporeal circulation, is a scientific 
technique which takes over the cardiac and the pulmonary functions temporarily during 
surgery on the heart and maintains blood circulation and oxygen supply of the body. It is 
usually referred to as heart-lung machine or simply the pump.  
 
The perfusionists operate the heart-lung machine with direction from the 
anaesthesiologists and the cardiac surgeons, who will establish the connection between 
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the patient and the pump. Cardiopulmonary bypass primarily aids in the circulation and 
oxygenation of blood mechanically bypassing the cardiac and pulmonary circulation. The 
perfusion of the rest of the body is done by the heart-lung machine while the operating 
site where the cardiac surgeon operate  is managed without much bleeding.  
 
The blood from the venous system is drained by gravity through the venous cannula 
usually placed in one of the bigger veins like femoral vein, vena cava or directly into the 
right atrium by the cardiac surgeon. The blood is collected in the reservoir through 
tubings filled with crystalloid. From the reservoir the blood is sent back to the body 
through tubing with the help of pumps after oxygenation and  after being warmed or 
cooled to the desired temperature into the ascending aorta or the femoral artery. The 
blood and the pump fluid  is heparinised to prevent clotting and activated clotting time is 
monitored at regular intervals to maintain adequate heparinization. At the end of the 
procedure before coming out of the bypass circuit, protamine is given to reverse any 
residual effects of heparin. Though cardiopulmonary bypass circuits initiate a systemic 
inflammatory response, it is being used successfully. ( 25 ) 
 
While the surgeon is operating on the heart the body temperature is being maintained in 
the range of 28ºC to 32ºC. The hypothermia during the bypass time helps in reducing the 
basal metabolic rate and decreasing the oxygen demand of the organ systems. The 
viscosity of the blood is usually increased with cooling but the dilution of the blood by 
the fluid in the circuit reduces the hematocrit, thus helping in the circulation.  
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HISTORY OF CARDIOPULMONARY BYPASS: ( 26 ) 
 
Dr. Clarence Dennis and his colleagues did the first ever known surgery by opening the 
heart on April 5, 1951 with both the cardiac and pulmonary functions being taken over 
temporarily by machinesl.Unfortunately the patient died because of an unexpected 
complicating cardiac lesion. Dr.Russell M. Nelson and Er. Eric Charles were the 
members of the team. Forest Dewey Dodrill did the first successful demonstration of the 
mechanical support of the left heart function on 3
rd
 July 1952.On May 6, 1953 ,John 
Gibbon did the first successful open heart procedure under CPB in an 18 year old lady. 
Robert Hooke was the first one to bring the concept of oxygenator in the seventeenth 
century. Initially bubble oxygenator and later membrane oxygenator were used. The 
high-performance microporous hollow-fibre oxygenators are developed and are being  
used in the modern days. 
 
USES OF CARDIO PULMONARY BYPASS: 
 
Cardiopulmonary bypass helps in operating heart lesions as it is technically difficult to do 
surgery on a beating heart. Open heart surgeries utilize cardiopulmonary bypass to 
maintain circulation during the duration of the procedure. The machine will take over the 
circulating and oxygenating function of the heart and the lungs.CPB is also employed in 
inducing hypothermia and maintain in that state for upto forty-five minutes without 
circulation. Hypothermia is very protective for brain. 
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CARDIOPLEGIA: ( 27 ) 
Cardioplegia is a technique by which the heart can be paralyzed with the help of 
chemical compounds or cold. It is usually done during heart surgeries where the heart 
should be empty and should not be contracting. It will give a bloodless field for the 
surgeon to operate on a non-beating, flaccid heart. It helps in decreasing the chances of 
air embolism during surgery on the heart chambers on the left side.It reduces the 
myocardial oxygen consumption. It can be given warm or cold. It can be antegrade  
through the coronary ostia or retrograde through the coronary veins.  
 
The cardioplegia can be completely crystalloid based or a mixture of cystallod with 
blood. The two most important types are Bretschneider’s HTK solution or the 
intracellular cardioplegia and St. Thomas No: 2 solution or the extracellular cardioplegia. 
The former is similar to that of the intracellular space and is mainly used for heart 
preservation during transplant. The later is similar to that of body serum and the arrest of 
the heart is caused from high potassium concentration. This high potassium concentration 
in the cardioplegia is one of the main reason that hypokalemia is less common in modern 
days than when cardioplegia was not used. The incidence of hyperkalemia is also 
attributed  to the use of the potassium-rich cardioplegia which was uncommon in the 
olden days when cardioplegia was not used. 
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CARDIOPLEGIA COMMONLY USED: ( 28 ) 
 
 Sodium Potassium Magnesium Calcium Bicarbon
ate 
Others 
Bretschneider’
sHTK 
solution 
 
15 
 
9 
 
4 
 
0.015 
 
- 
Histidin, 
Tryptophan, 
Potassium 
hydrogen-2- 
ketoglutarate 
St.Thomas 
No:2 
 
110 
 
16 
 
 
16 
 
 
 
1.2 
 
10 
 
Lidocaine 
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COMMON ADDITIVES TO CARDIOPLEGIA: (29, 30 , 31 ) 
 
 
 
 
                           
COMPONENT 
                            
                                  PURPOSE 
 
KCL 
 
Produce and maintain diastolic arrest 
 
THAM/ histidine 
 
Buffer 
 
Mannitol 
 
Osmolarity, Free radical scavenger 
 
Aspartate/ glutamate 
 
Metabolic substrate 
 
MgCl2 
 
Mitigates against effects of calcium 
 
CPD 
 
Lowers free calcium concentration 
 
Glucose 
 
Metabolic substrate 
 
Blood 
 
Oxygen-carrying capacity 
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CARDIOPULMONARY BYPASS AND POTASSIUM: ( 32 ) 
 
 It is very important to maintain a normal seum potassium level in cardio surgical 
patients. The serum potassium concentration in patients undergoing cardiopulmonary 
bypass is affected by several factors like 
 
 1   Diuretic use in the preoperative period 
 2   Myocardial protectant solution( cardioplegia) usage. – duration and volume 
 3   Priming solutions 
 4   Anaesthetic drugs 
 5   Peri-operative renal function 
 6   Ventilation and partial pressure of carbondioxide tension in blood 
 7   Arterial pH 
 8   Hypothermia 
 9   Insulin treatment of Hyperglycemia 
10   Mineralocorticoids 
                  
Potassium depletion may occur in nearly forty percent of patients undergoing valve 
surgery. The most commonly and the most frequently observed abnormality of potassium 
is hypokalemia.  
Before the introduction of cardioplegia hyperkalemia was rarely seen in cardiac surgery 
patients except in patients who have diadetes mellitus or kidney disease. In modern days, 
hyperkalemia is more common for a brief period immediately after the release of the 
cross-clamp of aorta. ( 33 ) ( 34 ) 
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Temperature also plays a role in serum potassium levels. Normothermic cardiopulmonary 
bypass requires more cardiplegia than the hypotermic bypass. This is the reason that 
hyperkalemia is more common in normothermic bypass.  
 
Potassium is also lost through kidneys and this loss depends on the urine flow implying 
that the concentration of potassium in the urine must remain nearly constant. ( 35 ) 
Increased potassium loss  in urine is usually seen in the postbypass period.  
 
Moffitt et al. ( 36 ) found out and reported that a greater decrease in serum potassium 
concentration occur when whole blood priming is used than when blood-free priming 
solution is used. The role of calcium is also important in maintaining potassium 
concentration while on cardiopulmonary bypass emphasizing to maintain 
normocalcemia.  
In hypothermic cardiopulmonary bypass the drop in potassium concentration  is 
proportional to the decrease in body temperature. ( 37 ) On the other hand, during the 
rewarming phase potassium concentration raises and hyperkalemia is the common 
finding.( 38 ) 
In hypothermic cardiopulmonary bypass an increase in blood glucose level ( 39 )  and a 
fall in insulin level occurs. Insulin causes an intracellular shift of potassium along with 
glucose. The levels of stress hormones like cortisol, aldosterone, and catecholamines  
 ( 40 )are increased during CPB and this may contribute to hypokalemia. An increase in 
urinary excretion of potassium is caused by aldosterone and cortisol where as 
catecholamines contribute by increasing the uptake of potassium by skeletal muscle.  
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Beta adrenergic antagonists ( 41 ) inhibit  skeletal muscle uptake of potassium but the 
hepatic release of potassium caused by beta adrenergic stimulation is not inhibited thus 
causing  hyperkalemia. Adding albumin ( 42 ) to the priming solution helps in bringing 
down the incidence of  hypokalemia as albumin molecules are negatively charged which 
may help to maintain adequate potassium concentration which is positively charged.  
 Potassium concentration is monitored very frequently during CPB. A strict 
normokalemia should be present for normal cardiac electrical activity  ( 43, 44 ). 
Increases in Peripheral vascular resistance is found to increases with bolus intravenous 
potassium of  8 mEq or more during CPB. With less than 8 MEq/ L doses, an initial fall  
may be there, which will be followed by a mild increase in systemic vascular resistance. ( 
45 ). 
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METHODOLOGY: 
STUDY SETTING: 
 The study was conducted in the Cardiothoracic operating suites and in the cardiothoracic 
intensive care units in Christian Medical College Hospital, Vellore. 
STUDY POPULATION: 
100 consecutive patients between 14 – 75 years  who underwent cardiac surgeries during 
the 6 months study period in Christian Medical College Hospital, Vellore. 
Inclusion criteria: 
 Age < 14 years  
 Chronic renal failure with serum creatinine > 1.6 mgms% 
STUDY PERIOD: 
The study was conducted over a period of 6 months between July to December 2012. A 
pilot study was conducted prior to the commencement of the study. 
 SAMPLE SIZE: ( 46 ) 
Sample size was calculated using the formula for single proportion – Absolute precision 
         Ƞ = Z2 P (1- P) 
                       d 
2  
  
where Ƞ = sample size 
           Z = Z statistic for a level of confidence i.e. for 95% is 1.96 
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            P = expected prevalence or proportion 
            d = precision   
Expected proportion is 60%. So P = 0.6 
For 10% precision, d = 0.1 
Desired confidence interval is 95%.    
Substituting the values for Z, P and D,  
 
 
           Ƞ = 1.96 2  ( 0.6 ) ( 1 – 0.6 ) 
                              0.1
2    
 
              
             Ƞ  = 92 
 
 
A total sample size of 92 patients would be needed for the study. 
This study had a total number of 100 patients with with 50 patients in each arm. 
 
 
SELECTION OF STUDY PATIENT: 
 
Prior permission was obtained from the institutional review board and the ethics  
committee to conduct the study. Patients who were scheduled for cardiac surgery were 
evaluated by the anaesthetist  in the preanaesthesia clinic and were explained in detail 
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about the study design. Patients who had given consent  and fulfilled the inclusion 
criteria were allocated into either of the group depending on their diuretic intake. 
 
INFORMED CONSENT: 
 
The informed consent was printed in the language familiar to the patient and in case the 
patient being illiterate,it was read out loud and explained by the attender. In case of 
minor patients the consent was taken from one of the parents or a legal guardian. 
 
DEFINITIONS: 
 
Duration of diuretic intake: Any patient who is on diuretic for more than a month are 
considered as being on chronic diuretic use. 
Hypokalemia is defined as a serum potassium of less than 3.5 MEq/L and Hyperkalemia 
in defined as a serum potassium of more than 5.5 MEq/L. 
Chronic renal failure: Patients whose serum creatinine value is more than 1.6 are 
considered to be in chronic renal failure and they were excluded from the study  
 
STUDY METHOD: 
 
The patients who fulfilled the inclusion criteria and gave consent were enrolled in the 
study. All medications that the patient was taking preoperatively were continued as per 
the routine schedule except ACE inhibitors. Tablet lorazepam and tablet omeprazole 
were given as premedication the night before and on the day of surgery.The preoperative 
comorbid conditions  like diabetic mellitus, chronic renal failure, the medication taken 
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like diuretics, ACE inhibitors, digoxin, Potassium supplements are all noted in the 
proforma. A baseline arterial blood gas ( ABG) is done and the values entered in the 
proforma. The ABG is repeated once the patient is on the cardiopulmonary bypass 
circuit, before coming out of bypass circuit and after coming out of the bypass circuit. 
Any incidence of hypokalemia or hyperkalemia in noted along with the interventions 
made to keep the potassium levels normal. In hypokalemia, potassium chloride ( kcl) is 
given and in hyperkalemia the treatment includes calcium, sodium bicarbonate, glucose 
insulin infusion. Any need for blood transfusion is noted as it may have an influence on 
serum potassium levels. The potassium rich cardioplegia is used to arrest the heart during 
cardiac surgery. The dose and the duration of cardioplegia is also noted. These patients 
are not extubated in the operation suite. They are shifted to the cardiothoracic intensive 
care unit ( I C U)with endotracheal tube and electively ventilated for a day. The patient is 
followed in the for first two postoperative days in the ICU. 
 
In the ICU,  arterial blood gas (ABG)  is repeated every four to six hourly. Any event of 
hypokalemia or hyperkalemia along with the interventions needed to keep the the 
potassium level normal in noted. All patients received nebulizations with salbutamol and 
ipratropium bromide after extubation .We could enroll 100 patients in this study with 50 
patients in the diuretic group and fifty I n the non-diuretic group. Once the adequate 
sample size has been achieved, all these datas were entered in the Epidata soft ware and 
exported into the Excel spreadsheet. 
 
STATISTICAL METHODS: ( 47 ) 
All the datas collected were analyzed using Generalized Estimating Equations. 
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RESULTS: 
 
Total number of 100 subjects who underwent cardiac surgery under cardiopulmonary 
bypass,  were enrolled in this study . None of them were excluded.  
The outcome variables between the two groups were analyzed using Generalized 
Estimating Equations. There were 50 subjects in the diuretics group and 50 subjects in 
the non-diuretics group.  
 
 
Figure 1: shows number of patients in the diuretic group and non-diuretic group. 
 
 
50 50 
DIURETIC  
NON DIURETIC 
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Among the 50 patients who were on long term diuretics, 43 of the patients were taking 
the loop diuretic furosemide and 7 patients were taking the potassium sparing diuretic 
spironolactone. 
 
  
Figure 2: shows the number of  patients on different types of diuretics. 
 
CLINICAL CHARACTERISTICS OF THE PATIENTS IN EACH GROUP: 
 
AGE DISTRIBUTION:  
The median age of the patients in the diuretic group was 43 years. And the median age in 
the non-diuretic group was 56 years. The patients with age less than 30 years were more 
in the diuretic group and with the age more than 60years were more in the non-diuretic 
43 
7 
DIURETIC 
FRUSEMIDE 
K SPARING 
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group.Between the age 30 to 60 years the patients were equally distributed in both the 
groups. 
  
  
Figure 3: shows the age distribution between the two groups. 
 
SEX DISTRIBUTION: 
 
There sex was equally distributed in the diuretic group with 25 male patients and 25 
female patients. In the non-diuretic group there were 37 male patients and 13 female 
patients. 
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 Figure 4: shows the sex distribution between both the groups. 
 
PREOPERATIVE CHARACTERISTICS BETWEEN BOTH THE GROUPS: 
 
ASSOCIATED SYSTEMIC DISEASES: 
Diabetes mellitus, hypertension and renal dysfunction were the major systemic diseases 
which affects the perioperative serum potassium levels. Their incidences varied between 
both the groups. 
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DIABETIC MELLITUS: 
 
Patients with diabetes mellitus were more in number in the non-diuretics group than in 
the diuretic group. Only 6% of the patients were diabetic in the diuretic group where as 
40% of the patients were diabetic in the non-diuretic group. 
 
 
 
Figure 5: shows the number of patients with diabetic mellitus in each group. 
 
RENAL DYSFUNCTION: 
Preoperative renal dysfunction was uncommon in both the groups. The serum creatinine 
of all the patients in the diuretic group was less than 1.5 mgms whereas in only 4 patients 
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in the non-diuretic group the serum creatinine was more than 1.5 mgms. The serum 
creatinine on the second postoperative day showed that 4 patients in the diuretic group 
newly had their serum creatinine raised above 1.5mgms whereas only one patient had his 
serum creatinine raised above 1.5mgms newly when compared to the preoperative value. 
 
Figure 6: Preoperative and postoperative serum creatinine in both groups. 
 
PATIENTS ON ACE INHIBITORS: 
 
Angiotensin converting enzyme inhibitors are known to cause hyperkalemia in patients 
with renal insufficiency and in patients who are on potassium sparing diuretics and 
potassium supplements. In our study only three patients were found to be on this drug of 
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which twowere in the diuretics group and one patient in the non-diuretics group.
  
Figure 7: shows number of patients on ACE inhibitors in each group. 
 
PATIENTS ON DIGOXIN AND POTASSIUM SUPPLEMENTS: 
 
The number of patients who received digoxin and potassium supplements were more in 
thediuretic group. As diuretics are known to cause hypokalemia and hpokalemia in 
patients on digoxin will lead to digoxin toxicity, almost all these patients were on 
potassium supplements. In the diuretic group 33 patients were on digoxin and 32 patients 
were on potassium supplements in the preoperative period whereas only 3 patients were 
on digoxin in the non-diuretics group and none of these patients were on potassium 
supplements in the preoperative period. 
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Figure 8: shows  the number of patients on digoxin in each group. 
 
 
 
 
Figure 9 : shows the number of patients on potassium supplements. 
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PREOPERATIVE DIAGNOSIS AND SURGERY: 
 
The nature of cardiac lesion for which the patient underwent surgery differ in both the 
groups. The patients with coronary artery disease underwent coronary artery bypass 
grafting( CABG ) and the patients with valvular heart disease underwent valve 
replacement surgeries. The valve replacement surgery included  mitral valve 
replacement, aortic valve replacement and double valve replacement. Few patients 
underwent a combination of a valve replacement and coronary artery bypass grafting.  
 
 
 
Figure 10: shows the type of surgery in each group. 
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 In the diuretic group Mitral valve replacement was the commonest surgery and in the  
non diuretic group coconary artery bypass grafting was the commonest surgery.Overall 
in the diuretic   group  25 patients had mitral valve replacement, 4 patients had aortic 
valve replacement, 11 patients had double valve replacement, 6 patients  had CABG and 
a valve replacement. In the non-diuretics group 35 patients had CABG, 6 patients had 
aortic valve replacement, 5 patients had mitral valve replacement, one patient had double 
valve replacement, one patient had CABG with a valve replacement and two patients had 
intracardiac repair. 
 
PERIOPERATIVE CHARACTERISTICS BETWEEN THE TWO GROUPS: 
 
CARDIOPLEGIA REQUIREMENT: 
All patients underwent cardiac surgical procedure under cardiopulmonary bypass and 
with cardioplegia. Cardioplegia, a potassium rich fluid given to arrest the heart which 
helps the surgeon to operate on a non-beating heart and a bloodless surgical field. Simple 
cardic procedures requires cardioplegia once which lasts for almost 20 minutes. More 
complicated procedures and double valve replacement may take a longer time that 
cardioplegia should be given more than once which may affect the serum potassium 
levels in the perioperative period. The figure 11, shows the details of cardioplegia 
requirements in both the groups. 
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Figure 11: shows the cardioplegia requirements in each group. 
 
The requirements of cardioplegia in the diuretic group was, once in 6 patients, twice in 
33patients and three times in 11 patients. In the non-diuretic group 10 patients required 
cardioplegia once, 37 patients required twice and 3 patients required cardioplegia three 
times. 
 
BLOOD AND BLOOD PRODUCTS REQUIREMENT: 
Cardiac surgeries require back-up of adequate numbers of blood and blood products in 
the perioperative period. Blood loss is common intraoperatively. The dilution of blood by 
the heart-lung machine will cause the haemoglobin to drop. Also post operative blood 
loss through the wound drain is also anticipated. The Figure 12, shows the intraoperative 
and the postoperative blood transfusion requirements. 
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Figure 12: shows the transfusion requirements in each group till second postoperative 
day. 
 
In the diuretic group 30 patients required packed cell transfusion intraoperatively, 7 
patients on the first postoperative day and 2 patients on the second postoperative day. In 
the non-diuretics group 24 patients required packed cell transfusion in the intraoperative 
period, 11 patients in the first postoperative day and 3 patients in the second 
postoperative day. 
 
HYPOKALEMIA AND POTASSIUM CORRECTION: 
The combination of factors like diuretics, hypothermia, cardiopulmonary bypass are 
expected to cause hypokalemia. Injection Potassium Chloride (kcl) is given as 
intravenous infusion to correct hypokalemia. Figure 13 and 14 shows the number of 
patients who required potassium correction and the amount of potassium needed to 
correct hypokalemia. In cardiac surgical patients a serum potassium level of more than 4 
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MEq/L is desired.As a result patients whose serum potassium is between 3.5 to 4 MEq/L 
also received potassium correction. Hence the amount of potassium chloride required to 
keep the serum potassium above 4 MEq/L is also recorded. 
 
 
Figure 13: shows the number of patients who needed kcl correction in the perioperative  
period. 
 
In the diuretic group 35 patients required potassium correction in the intraoperative 
period, 32 patients required correction in the intraoperative and the first postoperative 
day and 21 patients needed potassium correction all the three days. In the non-diuretics 
group 24 patients required kcl correction in the intraoperative period, 22 patients required 
correction in the intraoperative and the first postoperative day and 14 patients needed 
potassium correction all the three days.  
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Figure 14: shows the amount of kcl needed to keep serum potassium > 4MEq/L 
 
In the diuretic group 11 patients required less than 4 gms kcl, 25 patients required 4-8 
gms kcl and 14 patients required more than 8 gms kcl in all the 3 days to keep the serum 
potassium level more than 4MEq/L.In the non-diuretic group 12 patients required less 
than 4 gms kcl, 27 patients required 4-8 gms kcl and 11 patients required more than 8 
gms kcl in all the 3 days to keep the serum potassium level more than 4 MEq/L. 
 
INSULIN REQUIREMENT: 
Good glycemic control is important in cardiac surgical patients. Insulin is usually given 
as an infusion if blood sugars are high. Glucose-insulin infusion is started as a treatment 
of hyperkalemia. The requirement of insulin in the perioperative period between both 
groups is given in the figure 15. 
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Figure 15: shows the insulin requirement in the perioperative period in both the groups.  
 
In the diuretic group 6 patients require insulin in the intraoperative period, 11 patients 
needed insulin in the first postoperative day and 5 patients required insulin in the second 
postoperative day.In the non-diuretics group 14 patients required insulin in the 
intraoperative period, 24 patients required insulin in the first postoperative day and 2 
patients needed insulin in the second postoperative day. Incidently the non-diuretics 
group had more patients who are diabetic than in the diuretic group. 
 
TREATMENT WITH SODIUM BICARBONATE: 
7.5% sodium bicarbonate is given as intravenous bolus dose or as an infusion to correct 
acidosis. It is also used in the treatment of hyperkalemia. Maintaining the acid base 
balance is important to keep the serum potassium level with in the normal range. 
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Acidosis leads to hyperkalemia and alkalosis leads to hypokalemia due to 
intercompartmental shift of potassium ions. Figure 16, shows the details of sodium 
bicarbonate requirements in the perioperative period.  
 
 
 Figure 16: shows sodium bicarbonate requirement in the perioperative period in both the 
group. 
The requirement of sodium bicarbonate peaked in the first postoperative day with 23 
patients in the diuretic group and 33 patients in the nondiuretic group needing it. In both 
the diuretic and the non-diuretic group only 2 patients intraoperatively and 1 patient on 
the second postoperative day required treatment with sodium bicarbonate 
 
CALCIUM REQUIREMENT: 
Maintaining serum calcium level is important for the optimal contractility of the 
myocardium. Calcium is given intravenously when the ionic calcium is low. It is also 
given as the first line of drug in the treatment of hyperkalemia. Calcium protects the heart 
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from the deleterious effects of hyperkalemia though it will not lower serum potassium 
level. 
  
  
Figure 17: shows the number of patients treated with calcium in both groups. 
 
The total number of patients who required calcium is very less indicating hyperkalemia 
was uncommon in both the diuretic and non-diuretic groups. In the diuretic group only 2 
patients required calcium in the intraoperative period, 4 patients required calcium in the 
first post operative day and 4 patients needed calcium in the second postoperative day. In 
the non-diuretic group only 1 patient received calcium intraoperatively, 4 patients 
required calcium in the first postoperative day and 5 patients required calcium in the 
second postoperative day.  
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MAGNESIUM REQUIREMENT: 
 
Hypomagnesemia is one of the cause for perioperative arrhythmias. Hypokalemia 
associated hypomagnesemia will not respond to treatment with potassium correction 
alone. Magnesium should be given as an intravenous bolus in case of arrhythmias not 
responding to potassium correction. Most of the time magnesium is given empirically to 
treat arrhythmias which is not getting corrected even after potassium correction for 
hypokalemia. Figure 18 shows the details of magnesium requirement in the perioperative 
period. 
 
 
   
  
Figure 18: shows the number of patients treated with magnesium in both groups.  
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In the diuretic group, 3 patients required magnesium intraoperatively, 4 patients required 
magnesium on the first postoperative day and eight patients received magnesium in the 
second post operative day.In the non-diuretics groups, 3 patients required potassium in 
the intraoperative period, 2 patients in the first and the second postoperative day. 
 
PERIOPERATIVE FUROSEMIDE REQUIREMENTS: 
 
Furosemide commonly known as lasix is a loop diuretic used in the cardiac surgical 
patients. As fluid overload cannot be tolerated well in these patients in the postoperative 
period, furosemide administration is common in the post operative period.  
Also furosemide is given in the treatment of hyperkalemia so that potassium is excreted 
out. The following picture shows the details of furosemide requirements in the 
perioperative period.  
 
The following figure shows the details of furosemide requirement in both the diuretic and 
non diuretic group. 
70 
 
     
Figure: 19 shows the number of patients received lasix in the perioperative period in both 
the groups. 
 
The number of patients who received furosemide intraoperatively are 3 in the diuretic 
group and 4 in the non-diuretics group. In the first postoperative day, 20 patients in the 
diuretic group and 32 patients in the non diuretic group required furosemide. The 
requirements of furosemide on the second postoperative day are 23 patients in the 
diuretic group and 21 patients in the non-diuretics group.  
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DISCUSSION  
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DISCUSSION: 
 
 
Chronic use of diuretics like frusemide and thiazide is known to cause hypokalemia. In 
the cardiac patients who undergo open heart surgery, hypokalemia significantly increases 
the risk for perioperative arrhythmias.  
Most of these patients are on oral potassium supplements to prevent hypokalemia. Also 
patients who are on digoxin are known to develop toxicity if serum potassium is low.   
On the other hand patients who are taking potassium sparing diuretics and angiotensin 
converting enzyme inhibitors are known to develop hyperkalemia because of potassium 
retension by kidneys due to the inhibited effect of aldosterone. Patients with chronic 
renal failure poorly excrete potassium and are known for elevated serum potassium 
levels. 
Diabetic mellitus with insulin treatment cause intra cellular shift of potassium causing 
hypokalemia in the extracellular compartment. In contrast,  patients with diabetic 
nephropathy may develop hyperkalemia.  
This is an observational study which evaluated the role of long term preoperative 
diuretics on the perioperative serum potassium changes namely  hypokalemia and 
hyperkalemia.  
All the datas were analyzed using Generalized Estimating Equations. 
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In our study there was a clinically significant hypokalemia in the patients who were on 
long term diuretics preoperatively.  
In both diuretic and non diuretic groups serum potassium was higher in the sample 
immediately after cardioplegia comperd to baseline. This may be attributed to the high 
potassium in the cardioplegia solution.  
The  serum potassium levels tend to drop slightly after the cross clamp release and a 
further decrease  after coming of bypass. This trend seen in both the groups may be due 
to the diuretic effect of mannitol. 
 Most of the patients had serum potassium supplementation in the 1
st
 post operative day 
to keep the serum potassium levels between 4-4.5 mEq/L. even though the serum 
potassium trends in both the groups are similar, patients in the diuretic group had lower 
potassium levels compared to non diuretic group.  
However these changes are not statistically significant. Also there is no statistically 
significant difference in the potassium requirements. This may be partly due to the fact 
that potassium is a predominantly intracellular cation.   
These changes are similar to the results of  Babka R, Pifarre R titled ‘potassium 
replacement during cardiopulmonary bypass’. ( 48 ) 
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Graph 1 : shows the trend of serum potassium levels in the preoperative period(1), on 
pump(2), before coming out of bypass (3), after coming out of bypass(4), first post 
operative day (5) and the the second postoperative day(6). 
 
In a similar study published in 1990, Bhatt SB etal ( 49 ) reported a similar results where 
there was no significant  difference in the incidence of hypokalemia and the potassium 
requirement between two group.  
 
In an older study  by  , Saidi M etal ( 50 )     done in children between two group of 
patients with one group on diuretics and digitalis and other group not on these drug, it 
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was found that the chidren taking digitalis and diuretics had increased incidence of 
hypokalemia when comparing to the other group. Our study also reflects the same pattern 
with the incidence of hypokalemia was more in the diuretic group which was clinically 
significant but not statistically. 
 The incidence of hypokalemia during the intraoperative period was more in the diuretic 
group than the non-diuretic group. Only three patiets in the diuretic group and two 
patients in the non-diuretic group in whom hypokalemia settled with intraoperative 
correction of potassium.  
All the hundred patients included in this study in either group needed potassium 
correction at least once in either intraoperative or  in the first or second postoperative 
day. As many as 35 patients in the diuretic group had hypokalemia where as the number 
in the non-diuretic group was 24 in the intraoperative period.  
 In the diuretic group 21 patients required potassium correction all the three days where 
as only 14 patients required potassium correction all the three days in the non-diuretic 
group. The amount of kcl required to keep the potassium in the normal range also varied 
between the two groups. The number of subjects who required less than four grams of kcl 
correction were 11 in the diuretic group and 12 in the non-diuretic group. Similarly 25 
and 27 subjects in the diuretic and the non-diuretic group required a potassium correction 
of between 4 to 8 gms kcl, respectively. The subjects who required more than 8 gms kcl 
correction are also comparable between both the groups. It was 14 in the diuretic group 
and 11 in the non-diuretic group. 
The potassium requirement to keep the serum potassium above 4meq/l was higher in the 
non-diuretic group. This can be explained by the fact that the diabetic patients were more 
in the non-diuretic group. Most of these patients required insulin infusion in the 
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perioperative period. As insulin causes intracellular shift of potassium, these patients 
required more amount of potassium to keep the serum potassium level above 4- 4.5 
meq/L. This explains the reason for the increased potassium requirement in the non-
diuretic group. Diabetic mellitus and glucose intolerance were associated with 
statistically significant hyperkalemia in a study conducted by Donald O. Weber and 
Michael D. Yarnoz.( 40 ) 
 In a subgroup of patients in the diuretic group who are also on oral syp. potassium in the 
preoperative period, the amount of potassium correction needed to keep the serum 
potassium value above 4meq/l, is significantly lesser when compared to the patients who 
were not on potassium supplements preoperatively. This can be explained by the fact that 
even when the patients were taking diuretics, the potassium lost in the urine is constantly 
replenished by the potassium supplements. This was found to be a statistically significant 
finding with the p value of 0.000. 
The effects of parameters like haemoglobin, serum creatinine, serum bicarbonate, base 
excess, pH, Pco2 were all found to be clinically insignificant in affecting the 
perioperative potassium requirements in both the groups with the p values more than 0.7. 
  In our study 15 patients in the diuretic group and 7 patients in the non diuretic group 
required magnesium treatment. However this was not statistically significant. Magnesium 
supplementation is usually done on an empirical basis as a personal preference. We do 
not routinely measure serum magnesium in our patients. But assume that 
hypomagnesemia is  associated with hypokalemia.  
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In the diuretic group, there were only 7 patients who were taking spironolactone, an 
aldosterone antagonist and a potassium sparing diuretic. The analysis shows that the 
patients who were taking potassium sparing diuretic had required 0.07 gms kcl lower 
than who were not on that drug. This is statistically insignificant with the p value of 0.8. 
The subjects who were taking angiotensin converting enzyme inhibitors ( ACE 
inhibitors)were two patients in the diuretic group and only one patient in the non diuretic 
group. Though ACE inhibitors are expected to cause hyperkalemia , this is statistically 
insignificant  ( p = 0.7 ) in this study as overall only 3 patients were on this drug.  
 
Patients in both the groups received sodium bicarbonate either as a treatment for acidosis 
or in some instances as a treatment for hyperkalemia.26 patients in the diuretic group and 
36 patients in the non diuretic group required sodium bicarbonate treatment in the 
intraoperative and the post operative period. The incidence of alteration in the serum 
potassium levels in these patients is statistically insignificant with the p value of 0.2. 
Calcium is given in the perioperative period to correct hypocalcemia and also as a first 
line of treatment of hyperkalemia.10 patients in each of the groups receive calcium 
correction in the perioperative period. The effect of diuretic intake and calcium 
correction was not found to play any statistical significance ( p = 0.3) in the incidence of 
hypokalemia or hyperkalemia. 
 
 
The diuretic furosemide commonly known as frusemide is given to cardiac patients in the 
perioperative period to avoid or treat fluid overload. As frusemide is expected to excrete 
potassium along with urine the effect of usage of intraoperative and postoperative 
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frusemide was also studied. Only 3 patients in the diuretic group and 4 patients in the non 
diuretic group required frusemide intraoperatively. In the first post operative period 20 
patients in the diuretic group and 32 patients in the non diuretic group received lasix. In 
the second postoperative day, 23 patients in the diuretic group and 21 patients in the non 
diuretic group required frusemide. Among the patients who received perioperative 
frusemide treatment, those in the diuretic group required 0.17 gms less kcl than in the 
non diuretic group which is statistically insignificant. 
The role of cardioplegia, the high potassium rich fluid , in altering the serum potassium 
levels is also studied. In the diuretic group 6 patients received cardioplegia once, 33 
patients twice and 11 patients thrice. In the non diuretic group 10 patients received once, 
37 patients received twice and 3 patients received thrice. Adjusting for the cardioplegia, 
the analysis shows that the diuretic group required 0.05 gms less potassium than the 
nondiuretic group. However this is found to be statistically insignificant (p = 0.9 ).  
The role of blood transfusion in altering the serum potassium levels also studied between 
the two groups. The intraoperative need for blood transfusion was more in this study, 
with 30 patients in the diuretic group and 24 patients in the nondiuretic group received 
blood intraoperatively where as 11 patients in the diuretic group and 14 patients in the 
nondiuretic group received blood postoperatively. Adjusting for blood transfusion, the 
study shows that the diuretic group received 0.45 gms more kcl than the nondiuretic 
group which though clinically significant is not statistically significant ( p =0.5 ). 
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TABLE SHOWING RISK VARIABLES, THE MAGNITUTE OF CHANGE(B), 
THE CONFIDENCE INTERVAL AND THE P VALUE 
 
 
     RISK VARIABLES 
 
 
 
 
       
 
             B 
 
 
   95% CONFIDENCE     
INTERVAL 
 
 
      P VALUE 
Diuretic          
 
     
-0.107 -0.692   TO   0.478 0.720 
 K sparing            
 
          
  -0.073 -0.675   TO   0.530 0.813 
 Diabetic          
 
 
   
YES            
 
 
-1.331 -2.343  TO   -0.319 0.010 
NO             
 
 
0.183 -0.440  TO   0.807 0.564 
ACE Inhibitor 
 
 
   
YES            
 
 
-0.500 -3.272   TO  2.272 0.724 
NO             
 
 
-0.093 -0.681  TO 0.496 0.757 
K  supplements 
 
 
   
YES           
 
 
-2.043 -2.574   TO  -1.511 0.000 
NO            
 
 
-0.448 -1.180    TO 0.284 0.230 
Digoxin 
 
 
   
YES           
 
-0.334 -0.914  TO  0.245 0.258 
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NO            
 
 
0.231   -0.726  TO  1.184 0.636 
Creatinine 
 
 
-0.240 -0.861  TO 0.382 0.450 
Haemoglobin 
 
 
-0.040 -0.670  TO  0.590 0.901 
HCO3 
 
 
-0.082 -0.663  TO  0.498 0.781 
Base Excess 
 
 
-0.081 -0.666  TO 0.504 0.787 
PCO2 
 
 
-0.108 -0.692  TO  0.477 0.718 
Urea 
 
 
-0.072 -0.834 TO 0.689 0.852 
Cardioplegia 
 
 
-0.054 -0.852  TO 0.744 0.895 
Blood 
 
 
   
YES 
 
 
0.466 -0.908  TO 1.839 0.506 
NO 
 
 
0.200 -0.884  TO  1.284 0.718 
Insulin 
 
 
   
YES 
 
 
-0.684 -2.654 TO 1.285 0.496 
NO 
 
 
0.456 -0.205  TO 1.117 0.177 
Sodabicarb 
 
 
   
YES 
 
 
0.775 -0.670 TO  2.219 0.293 
NO 
 
 
0.327 -0.228  TO  0.882 0.248 
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Calcium 
 
 
   
YES 
 
 
1.714 -1.589 TO 5.017 0.309 
NO 
 
 
-0.253 -0.844 TO 0.338 0.402 
MgSo4 
 
 
   
YES 
 
 
-0.750 -5.194 TO 3.694 0.741 
NO 
 
 
-0.137 -0.705 TO 0.432 0.638 
Lasix 
 
 
   
YES 
 
 
-0.173 -1.248 TO 0.903 0.753 
NO 
 
 
0.650 -0.132  TO 1.431 0.103 
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CONCLUSION  
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CONCLUSIONS: 
 
The observations of the study on ‘perioperative serum potassium changes in patients 
undergoing open heart surgery under cardiopulmonary bypass: A comparative study 
between two group of patients – one group of patients on long term preoperative diuretics 
and the other group not on diuretics’ are 
1. There is no significant statistical difference in the incidence of hypokalemia  or 
hyperkalemia between the two group of patients. 
2.  A subgroup of patients who received preoperative oral potassium supplementation 
were found to be requiring 2 gms lesser potassium correction than in those who never 
received oral potassium in the preoperative period which is statistically significant with 
the p value of 0.000. 
3. The patients who were diabetic and also on long term diuretic therapy required 1.3 
gms lesser kcl to keep their potassium above 4 mEq/L than those who were not diabetic. 
This was found to be statistically significant with a p value of 0.010. 
4. The role of other preoperative medications like ACE inhibitors, digoxin, did not have 
any statistical significance in causing a difference in serum potassium levels in both the 
groups. 
5. The effects of parameters like haemoglobin, serum creatinine, serum bicarbonate, base 
excess, pH, Pco2 were all found to be clinically insignificant in affecting the 
perioperative potassium requirements in both the groups with the p values more than 0.7. 
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6. This study did not show any significant statistical difference in the perioperative 
requirement of sodium bicarbonate, calcium, magnesium ,glucose-insulin infusion and 
frusemide. 
7. The role of cardioplegia and blood transfusion were also found to be statistically not 
significant in causing a change in serum potassium levels between both the groups. 
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LIMITATIONS 
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 LIMITATIONS: 
1. Though the patients in the diuretics group required more interventions to keep the 
serum potassium in the normal range this study did not show any statistical difference. 
Had the study been done with a bigger sample size, it would have shown statistical 
significance in the incidence of hypokalemia in the diuretic group. 
2. The distribution of type of surgery between the two groups were not uniform. The 
valve replacement surgeries were common in the diuretic group whereas coronay artery 
bypass grafting was common in the non-diuretic group. 
3. In the same way there were more number of diabetic patients in the non-diuretic group 
comparing to the diuretic group. This might be a confounding factor. 
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RECOMMENDATION 
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RECOMMENDATIONS: 
1. We recommend that the study to be repeated with a bigger sample size. 
2. Confounding factors like the distribution of patients with diabetic mellitus mainly to 
the non-diuretic group should be addressed. 
3. The distribution of the type of surgery was also not uniform: such as  the valve 
replacement surgery in the diuretic group in contrast to the coronary artery bypass 
grafting in the non-diuretic group. This has to be addressed. 
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               PROFORMA FOR STUDY ON POTASSIUM CHANGES: 
NAME:  
AGE:             SEX:                 HOSPITAL  NO:                                   WT: 
SURGERY: 
PREOPERATIVE: 
MEDICATIONS:  1.                                                    DURATION: 1. 
                             2.                                                                          2. 
                             3.                                                                          3.  
INVESTIGATIONS:  HB:                  
                                  Na:                           K:                         Ca: 
                                  S.CREATININE: 
INTRAOPERATIVE: 
INV BASELINE ON BYPASS BEFORE 
COMING OUT 
OFF BYPASS POST OP 
HB      
PH      
HCO3      
BE      
Na/K      
CARDIOPLEGIA DOSAGE AND TIMINGS: 
1.                                 @ 
2.                                 @ 
3.                                 @                                                         
BLOOD AND PRODUCTS GIVEN  IF ANY: 
GLUCOSE-INSULIN INFUSION IF ANY:  INTRAOP: 
                                                                    POST OP: 
POTASSIUM CORRECTION IF ANY: INTRA OP: 
                                                              POST OP: 
INV POST OP:               DAY 1                                                                          DAY 2 
S.CREATININE: 
UREA: 
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CONSENT FORM 
       
PERIOPERATIVE SERUM POTASSIUM CHANGES IN PATIENTS 
UNDERGOING OPENHEART SURGERY UNDER 
CARDIOPULMONARY BYPASS:A COMPARATIVE STUDY BETWEEN 
TWO GROUP OF PATIENTS - ONE GROUP ON LONG TERM 
DIURETIS AND THE OTHER GROUP NOT ON DIURETICS. 
 
 
I, __________________________________________Hospital No:________________  
do hereby give my consent/ I give  consent  for  my __________________  (relation), 
Name______________________ Hospital   No ______________________to be enrolled 
in the study titled “Perioperative serum potassium changes in patients undergoing 
openheart surgery under cardiopulmonary bypass:A comparative study between two 
group of patents- one group on long term diuretics and the other group not on diuretics’. 
I have been given a copy of the Patient Information Sheet in a language that I understand. 
The study protocol has been explained to me and I have been given adequate time to ask 
questions and they have been answered to my satisfaction. [  ] 
I make this decision to be enrolled in this study freely, of my own volition, and without 
any external influence, coercion, or incentive. [  ] 
I understand that refusal to enroll in this study will not affect the standard of care 
provided to me, and that I can withdraw myself from the study anytime. [  ] 
 
By agreeing to be enrolled in this study, I give my consent for the following: 
I understand that no extra blood other than that for the routine test will be drawn for the 
purpose of the study. [  ] 
I understand that all usual standards of care will be followed during the study. [  ] 
I will not receive any financial returns for taking part in this study, whether in terms of 
actual cash, or as a reduction in the hospital bill. [  ] 
Signature                 __________________                                    __________________ 
 
                                  (Study Participant)               (Witness) (Relation to Participant)                                                                                                                           
Investigator: ____________________________                           Date:                 
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                             PATIENT INFORMATION SHEET 
 
 
Perioperative serum potassium changes in patients undergoing openheart surgery 
under cardiopulmonary bypass:A comparative study between two group of patients.- 
One group on long term diuretics and the other group not on diuretics. 
 Normal potassium level in the blood is important for the optimal functioning of the 
heart.Potassium level in the blood in  patients undergoing openheart surgery is affected 
by different parameters like inadequate dietry intake,preoperative use of diuretics and the 
use of potassium rich fluid during the surgery.Diuretics excrete potassium also along 
with water in the urine.This will cause low serum potassium levels affecting normal 
cardiac function. 
This study helps in the following way 
By doing this study we will come to know whether the potassium levels reduce 
significantly in patients who are taking long term diuretics in the preoperative period and 
to know whether this will affect the function of heart in patients on diuretics. 
How are you involved in this study?  
If you consent to participate in this study,the results of the blood tests done on you will 
be used to analyze the effects of diuretics.No extra tests or extra blood will be used other 
than that which is used routinely. 
There is no additional cost to you from this study. 
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